Terumo Aktie
15,90EUR | 0,10EUR | 0,63% |
WKN: 867003 / ISIN: JP3546800008
Personal
2021 | 2022 | 2023 | 2024 | 2025 | |
---|---|---|---|---|---|
Personal am Ende des Jahres | 26 482 | 28 294 | 30 207 | 30 591 | 0 |
Umsatz pro Mitarbeiter in Mio. EUR | 23,18 | 24,86 | 27,15 | 30,14 | 0,00 |
Bilanz (in Mio. JPY) - Aktiva
2021 | 2022 | 2023 | 2024 | 2025 | |
---|---|---|---|---|---|
Summe Umlaufvermögen | 523 966 | 558 713 | 611 396 | 722 116 | 723 496 |
Summe Anlagevermögen | 827 226 | 914 980 | 990 829 | 1 109 286 | 1 104 897 |
Summe Aktiva | 1 351 192 | 1 473 693 | 1 602 225 | 1 831 402 | 1 828 393 |
Bilanz (in Mio. JPY) - Passiva
2021 | 2022 | 2023 | 2024 | 2025 | |
---|---|---|---|---|---|
Summe Fremdkapital | 494 530 | 461 373 | 491 158 | 504 306 | 459 853 |
Summe Eigenkapital | 856 662 | 1 012 313 | 1 111 063 | 1 327 090 | 1 368 535 |
Summe Passiva | 1 351 192 | 1 473 686 | 1 602 221 | 1 831 396 | 1 828 393 |
Adresse
2-44-1 Hatagaya, 151-0072 Tokyo | |
Telefon | +81 (3) 3374-8111 |
Internet | https://www.terumo.co.jp |
Management
Hidenori Nishi
Independent Outside Director |
Hikaru Samejima
President & Chief Executive Officer |
James Rushworth
Chief Commercial Officer & Executive Officer |
Katsuya Takeuchi
Chief Information Officer & Executive Officer |
Kazuhisa Senshu
Chief Clinical & Regulatory Affairs Officer |
Keiya Ozawa
Outside Director |
Kosuke Matsumoto
Executive Officer & Manager-Sales Management |
Kyo Nishikawa
Director & Chief Human Resources Officer |
Masaichi Nakamura
Independent Outside Director |
Miho Mizuguchi
Chief Legal Officer & Compliance Manager |
Naoki Muto
Chief Financial & Accounting Officer |
Shinjiro Sato
Director |
Shouji Hatano
Director, Head-Compliance & Legal Affairs |
Soichiro Uno
Independent Outside Director |
Takanori Shibazaki
Director |
Toshiaki Takagi
Chairman |
Tsuyoshi Tomita
Senior Executive Officer & Manager-Medical Devices |